 Sarah Tevis
Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 40 | 2025 | 2253 | 10.050 |
Why?
| | Patient Reported Outcome Measures | 10 | 2025 | 403 | 4.290 |
Why?
| | Mastectomy | 15 | 2025 | 137 | 3.510 |
Why?
| | Mastectomy, Segmental | 9 | 2025 | 93 | 2.940 |
Why?
| | Postoperative Complications | 21 | 2025 | 2659 | 2.480 |
Why?
| | Health Literacy | 4 | 2025 | 168 | 2.390 |
Why?
| | Mammography | 5 | 2024 | 154 | 2.070 |
Why?
| | Mammaplasty | 4 | 2025 | 108 | 2.050 |
Why?
| | Surgical Procedures, Operative | 9 | 2024 | 259 | 1.990 |
Why?
| | Internship and Residency | 7 | 2022 | 1151 | 1.930 |
Why?
| | Patient Satisfaction | 7 | 2025 | 665 | 1.890 |
Why?
| | Comprehension | 4 | 2025 | 172 | 1.860 |
Why?
| | Drug Prescriptions | 4 | 2025 | 245 | 1.820 |
Why?
| | General Surgery | 5 | 2021 | 173 | 1.690 |
Why?
| | Pain, Postoperative | 6 | 2025 | 267 | 1.670 |
Why?
| | Patient Readmission | 13 | 2025 | 698 | 1.610 |
Why?
| | Analgesics, Opioid | 6 | 2025 | 1002 | 1.520 |
Why?
| | Quality of Life | 12 | 2025 | 2894 | 1.460 |
Why?
| | Patient Education as Topic | 3 | 2025 | 766 | 1.430 |
Why?
| | Breast Implants | 2 | 2022 | 19 | 1.350 |
Why?
| | Prophylactic Mastectomy | 2 | 2021 | 8 | 1.350 |
Why?
| | Humans | 94 | 2025 | 137782 | 1.260 |
Why?
| | Female | 67 | 2025 | 73465 | 1.250 |
Why?
| | Colectomy | 4 | 2016 | 100 | 1.160 |
Why?
| | Communication | 3 | 2023 | 879 | 1.120 |
Why?
| | Surveys and Questionnaires | 17 | 2025 | 5793 | 1.090 |
Why?
| | Patient Safety | 4 | 2021 | 315 | 1.090 |
Why?
| | Ovarian Neoplasms | 2 | 2023 | 565 | 1.060 |
Why?
| | Electronic Health Records | 3 | 2024 | 1070 | 1.050 |
Why?
| | Education, Medical, Graduate | 3 | 2021 | 486 | 1.020 |
Why?
| | Aged | 33 | 2025 | 24001 | 1.000 |
Why?
| | Ovariectomy | 3 | 2023 | 152 | 0.980 |
Why?
| | Breast | 3 | 2023 | 151 | 0.960 |
Why?
| | Adult | 34 | 2025 | 38023 | 0.950 |
Why?
| | Quality Improvement | 10 | 2021 | 1181 | 0.950 |
Why?
| | Patients | 2 | 2023 | 175 | 0.930 |
Why?
| | Surgeons | 4 | 2023 | 297 | 0.920 |
Why?
| | Nomograms | 2 | 2015 | 54 | 0.910 |
Why?
| | Meaningful Use | 1 | 2024 | 12 | 0.900 |
Why?
| | Sexual Health | 1 | 2025 | 59 | 0.860 |
Why?
| | Middle Aged | 32 | 2025 | 33554 | 0.850 |
Why?
| | Physicians | 2 | 2023 | 914 | 0.810 |
Why?
| | Patient-Centered Care | 4 | 2025 | 530 | 0.810 |
Why?
| | Preoperative Care | 2 | 2024 | 362 | 0.810 |
Why?
| | Lymphoma, Large-Cell, Anaplastic | 2 | 2022 | 20 | 0.810 |
Why?
| | Carcinoma, Ductal, Breast | 2 | 2025 | 83 | 0.800 |
Why?
| | Medical Errors | 2 | 2021 | 112 | 0.790 |
Why?
| | Hysterectomy | 2 | 2023 | 129 | 0.770 |
Why?
| | Practice Patterns, Physicians' | 5 | 2025 | 1313 | 0.770 |
Why?
| | Literacy | 1 | 2022 | 9 | 0.760 |
Why?
| | Social Media | 1 | 2025 | 158 | 0.760 |
Why?
| | Quality of Health Care | 3 | 2018 | 642 | 0.750 |
Why?
| | Artificial Intelligence | 1 | 2025 | 282 | 0.740 |
Why?
| | Colonic Neoplasms | 1 | 2024 | 258 | 0.730 |
Why?
| | Delayed Diagnosis | 2 | 2020 | 91 | 0.730 |
Why?
| | Lymph Node Excision | 4 | 2025 | 171 | 0.720 |
Why?
| | Referral and Consultation | 3 | 2024 | 786 | 0.720 |
Why?
| | Paternalism | 1 | 2021 | 4 | 0.720 |
Why?
| | Chemoprevention | 1 | 2021 | 92 | 0.690 |
Why?
| | Oxycodone | 1 | 2021 | 42 | 0.690 |
Why?
| | Neoplasm Recurrence, Local | 4 | 2025 | 1080 | 0.690 |
Why?
| | Access to Information | 1 | 2021 | 49 | 0.690 |
Why?
| | Retrospective Studies | 24 | 2025 | 15682 | 0.680 |
Why?
| | Surgical Wound Infection | 2 | 2022 | 307 | 0.670 |
Why?
| | Cancer Survivors | 1 | 2025 | 288 | 0.670 |
Why?
| | Specialties, Surgical | 1 | 2021 | 75 | 0.660 |
Why?
| | Personnel Selection | 1 | 2021 | 78 | 0.660 |
Why?
| | Sentinel Lymph Node Biopsy | 6 | 2025 | 115 | 0.650 |
Why?
| | Carcinoma, Lobular | 1 | 2020 | 49 | 0.650 |
Why?
| | Risk Management | 1 | 2020 | 93 | 0.650 |
Why?
| | Faculty | 1 | 2021 | 147 | 0.640 |
Why?
| | Breast Implantation | 1 | 2019 | 13 | 0.630 |
Why?
| | Length of Stay | 10 | 2025 | 1215 | 0.620 |
Why?
| | Prognosis | 10 | 2025 | 4039 | 0.610 |
Why?
| | Radiology | 1 | 2021 | 180 | 0.610 |
Why?
| | Ileus | 2 | 2015 | 12 | 0.600 |
Why?
| | Education, Medical, Undergraduate | 1 | 2021 | 188 | 0.590 |
Why?
| | Sentinel Lymph Node | 1 | 2018 | 45 | 0.580 |
Why?
| | Financing, Personal | 1 | 2018 | 26 | 0.580 |
Why?
| | Intraoperative Care | 1 | 2018 | 52 | 0.570 |
Why?
| | HLA Antigens | 1 | 2019 | 240 | 0.560 |
Why?
| | Interviews as Topic | 1 | 2021 | 797 | 0.560 |
Why?
| | Patient Acceptance of Health Care | 1 | 2024 | 807 | 0.550 |
Why?
| | Neoplasm, Residual | 1 | 2018 | 133 | 0.550 |
Why?
| | Fellowships and Scholarships | 1 | 2021 | 307 | 0.550 |
Why?
| | Pain Management | 1 | 2020 | 358 | 0.520 |
Why?
| | Follow-Up Studies | 9 | 2025 | 5136 | 0.510 |
Why?
| | Students, Medical | 1 | 2021 | 348 | 0.510 |
Why?
| | Anastomotic Leak | 1 | 2016 | 41 | 0.500 |
Why?
| | Research Design | 1 | 2022 | 1139 | 0.500 |
Why?
| | Pancreatic Neoplasms | 1 | 2024 | 938 | 0.500 |
Why?
| | Genetic Testing | 1 | 2018 | 462 | 0.480 |
Why?
| | Prospective Studies | 8 | 2022 | 7623 | 0.470 |
Why?
| | Prophylactic Surgical Procedures | 1 | 2015 | 7 | 0.470 |
Why?
| | Opioid-Related Disorders | 1 | 2022 | 515 | 0.450 |
Why?
| | Hospitals, Teaching | 1 | 2014 | 118 | 0.430 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 754 | 0.420 |
Why?
| | Health Care Surveys | 2 | 2015 | 565 | 0.420 |
Why?
| | Neoplasms | 3 | 2024 | 2673 | 0.420 |
Why?
| | Burnout, Professional | 1 | 2020 | 442 | 0.410 |
Why?
| | United States | 13 | 2025 | 14870 | 0.410 |
Why?
| | Salpingo-oophorectomy | 2 | 2023 | 18 | 0.410 |
Why?
| | Body Image | 2 | 2025 | 95 | 0.400 |
Why?
| | Carcinoma | 1 | 2015 | 240 | 0.400 |
Why?
| | Longitudinal Studies | 3 | 2024 | 2860 | 0.390 |
Why?
| | Biomarkers, Tumor | 2 | 2020 | 1276 | 0.390 |
Why?
| | Rectal Neoplasms | 1 | 2013 | 149 | 0.380 |
Why?
| | Surgical Oncology | 2 | 2022 | 27 | 0.380 |
Why?
| | Stress, Psychological | 1 | 2020 | 1108 | 0.370 |
Why?
| | Risk Factors | 16 | 2025 | 10407 | 0.370 |
Why?
| | Time-to-Treatment | 1 | 2013 | 205 | 0.370 |
Why?
| | Neoadjuvant Therapy | 3 | 2025 | 404 | 0.360 |
Why?
| | Gastroplasty | 1 | 2011 | 30 | 0.360 |
Why?
| | Clinical Competence | 2 | 2021 | 1129 | 0.360 |
Why?
| | Reoperation | 4 | 2025 | 573 | 0.350 |
Why?
| | Male | 25 | 2024 | 67906 | 0.350 |
Why?
| | Thyroid Neoplasms | 1 | 2015 | 343 | 0.340 |
Why?
| | Aged, 80 and over | 9 | 2025 | 7637 | 0.330 |
Why?
| | Educational Status | 2 | 2022 | 470 | 0.320 |
Why?
| | Gastric Bypass | 1 | 2011 | 119 | 0.320 |
Why?
| | Wisconsin | 5 | 2016 | 101 | 0.320 |
Why?
| | Income | 2 | 2022 | 203 | 0.310 |
Why?
| | Databases, Factual | 5 | 2019 | 1357 | 0.300 |
Why?
| | Incidence | 5 | 2015 | 2804 | 0.290 |
Why?
| | Pandemics | 3 | 2021 | 1639 | 0.290 |
Why?
| | Chemotherapy, Adjuvant | 2 | 2023 | 389 | 0.280 |
Why?
| | Comorbidity | 3 | 2019 | 1623 | 0.280 |
Why?
| | Lymphatic Metastasis | 4 | 2025 | 352 | 0.270 |
Why?
| | Obesity, Morbid | 1 | 2011 | 264 | 0.270 |
Why?
| | Qualitative Research | 2 | 2024 | 1399 | 0.260 |
Why?
| | Preoperative Period | 2 | 2024 | 129 | 0.240 |
Why?
| | Gynecologic Surgical Procedures | 1 | 2025 | 63 | 0.230 |
Why?
| | Physician-Patient Relations | 2 | 2021 | 558 | 0.230 |
Why?
| | Video Recording | 1 | 2025 | 180 | 0.220 |
Why?
| | Inappropriate Prescribing | 1 | 2025 | 55 | 0.220 |
Why?
| | Reading | 1 | 2025 | 135 | 0.220 |
Why?
| | Patient Portals | 1 | 2024 | 45 | 0.210 |
Why?
| | Rosa | 1 | 2023 | 1 | 0.210 |
Why?
| | Operating Rooms | 2 | 2023 | 123 | 0.210 |
Why?
| | Sexually Transmitted Diseases | 1 | 2025 | 161 | 0.210 |
Why?
| | Information Seeking Behavior | 1 | 2023 | 34 | 0.200 |
Why?
| | Hospital Mortality | 3 | 2016 | 911 | 0.200 |
Why?
| | Patient Navigation | 1 | 2024 | 81 | 0.200 |
Why?
| | Internet | 2 | 2024 | 655 | 0.200 |
Why?
| | Focus Groups | 1 | 2025 | 530 | 0.190 |
Why?
| | Antineoplastic Agents | 1 | 2013 | 2129 | 0.190 |
Why?
| | Delivery of Health Care | 2 | 2022 | 951 | 0.190 |
Why?
| | Logistic Models | 3 | 2015 | 2075 | 0.180 |
Why?
| | Electronics | 1 | 2021 | 76 | 0.180 |
Why?
| | Bone Marrow | 2 | 2020 | 286 | 0.180 |
Why?
| | Patient Discharge | 2 | 2020 | 897 | 0.170 |
Why?
| | Language | 1 | 2024 | 294 | 0.170 |
Why?
| | Receptor, ErbB-2 | 1 | 2023 | 341 | 0.170 |
Why?
| | Patient Participation | 1 | 2024 | 426 | 0.170 |
Why?
| | Habits | 1 | 2020 | 49 | 0.170 |
Why?
| | Checklist | 1 | 2021 | 93 | 0.170 |
Why?
| | Feasibility Studies | 1 | 2024 | 963 | 0.170 |
Why?
| | Analgesia | 1 | 2021 | 94 | 0.170 |
Why?
| | Time Factors | 4 | 2022 | 6834 | 0.170 |
Why?
| | Interdisciplinary Communication | 1 | 2021 | 191 | 0.160 |
Why?
| | Schools, Medical | 1 | 2021 | 147 | 0.160 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2020 | 80 | 0.160 |
Why?
| | Nipples | 1 | 2019 | 9 | 0.160 |
Why?
| | Genotyping Techniques | 1 | 2019 | 75 | 0.160 |
Why?
| | Adaptation, Psychological | 2 | 2023 | 662 | 0.160 |
Why?
| | Organ Sparing Treatments | 1 | 2019 | 36 | 0.160 |
Why?
| | Health Education | 1 | 2022 | 341 | 0.150 |
Why?
| | Program Evaluation | 2 | 2021 | 901 | 0.150 |
Why?
| | Axilla | 3 | 2025 | 47 | 0.150 |
Why?
| | Mentors | 1 | 2021 | 206 | 0.150 |
Why?
| | Program Development | 1 | 2021 | 368 | 0.150 |
Why?
| | Neoplasm Invasiveness | 1 | 2020 | 512 | 0.150 |
Why?
| | Hospitals, University | 2 | 2016 | 182 | 0.150 |
Why?
| | Breast Diseases | 1 | 2018 | 22 | 0.150 |
Why?
| | Career Choice | 1 | 2020 | 219 | 0.140 |
Why?
| | Surface Properties | 1 | 2019 | 413 | 0.140 |
Why?
| | Gene Frequency | 1 | 2019 | 521 | 0.140 |
Why?
| | Patient Care Team | 2 | 2021 | 631 | 0.140 |
Why?
| | Postoperative Period | 2 | 2021 | 342 | 0.140 |
Why?
| | Salaries and Fringe Benefits | 1 | 2018 | 56 | 0.140 |
Why?
| | Biopsy | 1 | 2022 | 1130 | 0.140 |
Why?
| | Pilot Projects | 1 | 2023 | 1713 | 0.140 |
Why?
| | Sexual Behavior | 1 | 2022 | 485 | 0.140 |
Why?
| | Guideline Adherence | 1 | 2022 | 556 | 0.140 |
Why?
| | Photography | 1 | 2018 | 96 | 0.140 |
Why?
| | Confidentiality | 1 | 2018 | 73 | 0.140 |
Why?
| | Risk Assessment | 2 | 2018 | 3461 | 0.130 |
Why?
| | Age Factors | 2 | 2025 | 3305 | 0.130 |
Why?
| | Neoplasm Staging | 3 | 2025 | 1389 | 0.130 |
Why?
| | Informed Consent | 1 | 2018 | 183 | 0.130 |
Why?
| | Anxiety | 1 | 2024 | 1043 | 0.130 |
Why?
| | Practice Guidelines as Topic | 1 | 2025 | 1586 | 0.130 |
Why?
| | RNA, Viral | 1 | 2020 | 656 | 0.130 |
Why?
| | Markov Chains | 1 | 2017 | 126 | 0.130 |
Why?
| | Alleles | 1 | 2019 | 892 | 0.130 |
Why?
| | Multivariate Analysis | 3 | 2015 | 1509 | 0.120 |
Why?
| | Palliative Care | 1 | 2022 | 758 | 0.120 |
Why?
| | Proctocolectomy, Restorative | 1 | 2015 | 20 | 0.110 |
Why?
| | Medicare | 1 | 2020 | 773 | 0.110 |
Why?
| | Curriculum | 1 | 2021 | 996 | 0.110 |
Why?
| | Treatment Outcome | 3 | 2014 | 10837 | 0.110 |
Why?
| | Bayes Theorem | 1 | 2016 | 407 | 0.110 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1692 | 0.110 |
Why?
| | Rectum | 1 | 2015 | 185 | 0.110 |
Why?
| | Colitis, Ulcerative | 1 | 2015 | 136 | 0.100 |
Why?
| | Emergencies | 1 | 2014 | 164 | 0.100 |
Why?
| | Urinary Tract Infections | 1 | 2015 | 188 | 0.100 |
Why?
| | Digestive System Surgical Procedures | 1 | 2013 | 106 | 0.100 |
Why?
| | Regression Analysis | 1 | 2015 | 1024 | 0.100 |
Why?
| | Postoperative Care | 1 | 2014 | 261 | 0.100 |
Why?
| | Disease-Free Survival | 1 | 2013 | 686 | 0.090 |
Why?
| | Case-Control Studies | 1 | 2019 | 3569 | 0.090 |
Why?
| | Global Health | 1 | 2015 | 386 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1775 | 0.090 |
Why?
| | Kaplan-Meier Estimate | 1 | 2013 | 889 | 0.090 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2427 | 0.090 |
Why?
| | Combined Modality Therapy | 1 | 2013 | 1236 | 0.080 |
Why?
| | Proportional Hazards Models | 1 | 2013 | 1266 | 0.080 |
Why?
| | Treatment Failure | 1 | 2011 | 356 | 0.080 |
Why?
| | Adolescent | 4 | 2016 | 21574 | 0.080 |
Why?
| | Models, Biological | 1 | 2017 | 1783 | 0.080 |
Why?
| | Lymph Nodes | 2 | 2023 | 491 | 0.080 |
Why?
| | Disease Progression | 1 | 2017 | 2760 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 1 | 2021 | 3577 | 0.080 |
Why?
| | Cohort Studies | 1 | 2019 | 5750 | 0.070 |
Why?
| | Mutation | 1 | 2019 | 3959 | 0.070 |
Why?
| | Colorectal Neoplasms | 1 | 2015 | 807 | 0.070 |
Why?
| | Young Adult | 4 | 2019 | 13240 | 0.070 |
Why?
| | Laparoscopy | 1 | 2011 | 466 | 0.060 |
Why?
| | Weight Loss | 1 | 2011 | 788 | 0.060 |
Why?
| | Operative Time | 1 | 2025 | 145 | 0.060 |
Why?
| | Workflow | 1 | 2025 | 165 | 0.050 |
Why?
| | Mastectomy, Modified Radical | 1 | 2022 | 6 | 0.050 |
Why?
| | Intraoperative Period | 1 | 2021 | 59 | 0.040 |
Why?
| | Survival Rate | 1 | 2025 | 1973 | 0.040 |
Why?
| | Medical Oncology | 1 | 2022 | 293 | 0.040 |
Why?
| | Organizational Culture | 1 | 2021 | 152 | 0.040 |
Why?
| | BRCA2 Protein | 1 | 2019 | 63 | 0.040 |
Why?
| | BRCA1 Protein | 1 | 2019 | 76 | 0.040 |
Why?
| | Pain Measurement | 1 | 2021 | 524 | 0.040 |
Why?
| | Medical Records | 1 | 2018 | 177 | 0.030 |
Why?
| | ROC Curve | 1 | 2017 | 554 | 0.030 |
Why?
| | Sex Factors | 1 | 2021 | 2077 | 0.030 |
Why?
| | Health Facility Size | 1 | 2014 | 11 | 0.030 |
Why?
| | Hospitals, High-Volume | 1 | 2014 | 44 | 0.030 |
Why?
| | Confidence Intervals | 1 | 2014 | 329 | 0.030 |
Why?
| | Social Work | 1 | 2014 | 85 | 0.030 |
Why?
| | Quality Indicators, Health Care | 1 | 2015 | 307 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2015 | 593 | 0.020 |
Why?
| | Health Care Costs | 1 | 2015 | 398 | 0.020 |
Why?
| | Health Status | 1 | 2016 | 792 | 0.020 |
Why?
| | Odds Ratio | 1 | 2014 | 1070 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2015 | 740 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 5478 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2014 | 496 | 0.020 |
Why?
| | Population Surveillance | 1 | 2013 | 482 | 0.020 |
Why?
| | Prevalence | 1 | 2016 | 2734 | 0.020 |
Why?
| | Chronic Disease | 1 | 2014 | 1794 | 0.020 |
Why?
| | Obesity | 1 | 2015 | 2993 | 0.010 |
Why?
|
|
Tevis's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|